Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants for Pharmacogenomics Research FY 06 Mar. 12 -- April 9*

Premium
NIH Grants for Pharmacogenomics Research FY'06
Mar. 12 — April 9*
City, State, or Country Name
Organization Name
Principal Investigator
Award
Title
California
Portola Valley
Gene Security Network Rabinowitz, Matthew $218,859 Integrating, Validating & Applying Pharmacogenetic Data
San Francisco University of California
San Francisco
Hamilton,
Steven P
$1,764,980 Pharmacogenomics of Antidepressant Response
Mountain View Perlegen Sciences Stokowski, Renee P $1,144,992 Signature SNPs to distinguish Yersinia pestis strains
La Jolla University of California
San Diego
Nigam,
Sanjay K
$339,181 SNPs in Handling of Small Pox Antivirals & Other Drugs
University of California
San Diego
Yuan,
Jason Xj
$150,788 SNPs in Idiopathic Pulmonary Artierial Hypertension
Florida
Tampa
H. Lee Moffitt Cancer Center Bepler,
Gerold
$286,873 Pharmacogenomics of Neoadjuvant Gemcitabine-Pemetrexed
Edgerton,
Mary E
$217,802 Clinical & Microarray Data Predict Lung Cancer Outcomes
Massachusetts
Boston
Dana-Farber Cancer Institute Johnson,
Bruce E
$289,347 EGFR Mutations in non-Small Cell Lung Cancer
Meyerson, Matthew L $325,631 Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
Tufts University Greenblatt, David J $232,163 CYP3A Function in Aging African Americans
Michigan
Ann Arbor
University of Michigan at
Ann Arbor
Waskell,
Lucy A
$296,151 Participation of Cytochrome b5 in Anesthetic Metabolism
New Hampshire
Hanover
Dartmouth College Hwa, John $312,285 Pharmacogenetics of the human prostacyclin receptor.
Pennsylvania
Philadelphia
Wistar Institute Showe,
Louise C
$311,770 Microarray Analysis of Responsiveness of CTCL IL-12
Tennessee
Memphis
St. Jude's Children's Research Hospital Schuetz,
Erin G
$286,300 PXR: Regulation and Pharmacogenomics
Texas
Houston
University of Texas MD Anderson Cancer Center Cinciripini,
Paul M
$531,714 Pharmacogenetics, Emotional Reactivity & Smoking
The Woodlands Molecular Logix Pienkos,
Philip T
$401,535 Creating Clinically Relevant EGFR Antagonists
Virginia
Richmond
Virginia Commonwealth University Manjili,
Masoud H
$229,888 Enhancement of HER-2/neu-based therapy using HSP11
Washington
Pullman
Washington State University Jones,
Jeffrey P
$270,730 Cytochrome P450 Models for Risk Assessment
Seattle University of Washington Rettie,
Allan E
$327,944 Pharmacogenetics of ADRs: Warfarin Toxicity
Fred Hutchinson Cancer Research Center Potter,
John D
$842,309 Aspirin, UGT1A6 Genotype, and Colon Gene Expression
Wisconsin
Milwaukee
Medical College of Wisconsin Stephens, Michael C $126,900 ABC Transporter Pharmacogenetics: Impact on Thiopurine Therapy
*SOURCE: US National Institutes of Health

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.